You do not have the latest flash plugin or you have disabled javascript.

New federal drug safety bill under consideration

May 4th, 2007 by Erich Vieth

Consumers Union is reporting on developments relating to a new FDA bill regarding drug safety:

Consumers Union is urging the Senate to approve strong prescription drug-safety provisions this week in a major Food and Drug Administration bill, and resist attempts to weaken the bill when it comes to triggering quick safety action or moderating mass advertising of a new drug when there are signs of danger.

“This bill will save countless lives in the years to come by giving the FDA more funding and flexible tools to ensure the safety of prescription drugs in the marketplace,” Jim Guest, president and CEO of Consumers Union, publisher of Consumer Reports, wrote in a letter to the Senate.

 

Simon Passanante is nationally recognized as a result of its successful handling of jury trials on a wide variety of cases. You are invited to view the firm’s notable verdicts and settlements. Much of the information on this site is presented through videos. Other pages of this site concern Simon Passanante’s honors and awards, testimonials from clients and referring attorneys, and safety information. Our employee directory is here. If you have any questions for us, email us. See this page for important legal disclosures and to learn about contingent fees. For updates regarding Simon Passanante, we invite you to explore our law blogs.

Simon Passanante PC

701 Market Street

Suite 1450

St. Louis, Missouri 63101

314.241.2929

Toll Free: 877.767.3108

Close
E-mail It